The effects of probiotics supplementation on serum markers of oxidative stress in relapsing-remitting multiple sclerosis: a randomised, double-blind, placebo-controlled clinical trial
In: Beneficial MicrobesSearch for other papers by N. Mohy in
Current site
Google Scholar
Search for other papers by S. Sanaie in
Current site
Google Scholar
Search for other papers by S. Rahnemayan in
Current site
Google Scholar
Search for other papers by M. Yousefi in
Current site
Google Scholar
Search for other papers by M. Talebi in
Current site
Google Scholar
Research Center for Evidence-Based Medicine, Iranian EBM Center: A Joanna Briggs Institute Center of Excellence, Tabriz University of Medical Sciences, Tabriz, Iran
Tabriz USERN Office, Universal Scientific Education and Research Network (USERN), Tabriz, Iran
Search for other papers by A. Naseri in
Current site
Google Scholar
Abstract
Oxidative stress is a significant contributor to neuronal damage in multiple sclerosis (MS), marked by an imbalance in reactive oxygen species and antioxidant defences. Probiotics may modulate oxidative stress and improve antioxidant levels. This double-blind, randomised, placebo-controlled clinical trial aimed to evaluate the effects of probiotics supplementation on serum oxidative stress markers and endogenous antioxidants in patients with relapsing-remitting MS (RRMS). Ninety RRMS patients with expanded disability status scale [EDSS] < 4 were randomised into two groups: a probiotics group (Lactocare®) and a placebo group, and received the interventions twice daily for four months. Serum levels of oxidative stress markers (malondialdehyde [MDA]), endogenous antioxidants (glutathione peroxidase [GPx] activity, superoxide dismutase [SOD], catalase activity [CAT], glutathione [GSH]), and total antioxidant capacity (TAC) were measured at baseline and post-treatment. Fifty-five patients, including 26 patients in the probiotic group and 29 patients in the placebo group, completed the study. Both groups showed significant within-group improvements in GPx activity, SOD, and GSH levels, as well as reductions in MDA levels (
Iranian Registry of Clinical Trials: IRCT20220713055465N2, registration date: 2023.5.9
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Adamczyk, B. and Adamczyk-Sowa, M., 2016. New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis. Oxidative Medicine and Cellular Longevity 2016: 1973834.
-
Amirani, E., Milajerdi, A., Mirzaei, H., Jamilian, H., Mansournia, M.A., Hallajzadeh, J. and Ghaderi, A., 2020. The effects of probiotic supplementation on mental health, biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 49: 102361.
-
Asghari, K.M., Dolatkhah, N., Ayromlou, H., Mirnasiri, F., Dadfar, T. and Hashemian, M., 2023. The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial. Scientific Reports 13: 18577. https://doi.org/10.1038/S41598-023-46047-6
-
Chakamian, K., Robat-Jazi, B., Moghadasi, A.N., Mansouri, F., Nodehi, M., Motevaseli, E., Izad, M., Yekaninejad, S., Shirzad, M., Bidad, K., Oraei, M., Ansaripour, B. and Saboor-Yaraghi, A.A., 2023. Immunosuppressive effects of two probiotics, Lactobacillus paracasei DSM 13434 and Lactobacillus plantarum DSM 15312, on CD4+ T cells of multiple sclerosis patients. Iranian Journal of Allergy, Asthma and Immunology 22: 34-45. https://doi.org/10.18502/IJAAI.V22I1.12004
-
Chalah, M.A. and Ayache, S.S., 2017. Deficits in social cognition: an unveiled signature of multiple sclerosis. Journal of the International Neuropsychological Society 23: 266-286.
-
Dobson, R. and Giovannoni, G., 2019. Multiple sclerosis – a review. European Journal of Neurology 26: 27-40.
-
Feng, T. and Wang, J., 2020. Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review. Gut Microbes 12: 1801944.
-
Heshmati, J., Farsi, F., Shokri, F., Rezaeinejad, M., Almasi-Hashiani, A., Vesali, S. and Sepidarkish, M., 2018. A systematic review and meta-analysis of the probiotics and synbiotics effects on oxidative stress. Journal of Functional Foods 46: 66-84.
-
Kouchaki, E., Tamtaji, O.R., Salami, M., Bahmani, F., Daneshvar Kakhaki, R., Akbari, E., Tajabadi-Ebrahimi, M., Jafari, P. and Asemi, Z., 2017. RETRACTED: Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition 36: 1245-1249. https://doi.org/10.1016/J.CLNU.2016.08.015
-
Naseri, A., Sanaie, S., Rahnemayan, S., Mosaddeghi-Heris, R., Talebi, M. and Talebi, M., 2025. The effects of probiotic supplementation on level of disability, depressive symptoms and cognitive outcomes in relapsing-remitting multiple sclerosis patients: a randomized double-blind placebo-controlled trial. Pharmaceutical Sciences 31: 322-329. https://doi.org/10.34172/PS.025.41013
-
Nicholas, J., Morgan-Followell, B., Pitt, D., Racke, M.K. and Boster, A., 2012. New and emerging disease-modifying therapies for relapsing-remitting multiple sclerosis: what is new and what is to come. Journal of Central Nervous System Disease 4: JCNSD-S6692.
-
Oh, J., Vidal-Jordana, A. and Montalban, X., 2018. Multiple sclerosis: clinical aspects. Current Opinion in Neurology 31: 752-759.
-
Pegoretti, V., Swanson, K.A., Bethea, J.R., Probert, L., Eisel, U.L.M. and Fischer, R., 2020. Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development. Oxidative Medicine and Cellular Longevity 2020: 7191080.
-
Rahimlou, M., Nematollahi, S., Husain, D., Banaei-Jahromi, N., Majdinasab, N. and Hosseini, S.A., 2022. Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Frontiers in Neuroscience 16: 901846. https://doi.org/10.3389/FNINS.2022.901846/BIBTEX
-
Salami, M., Kouchaki, E., Asemi, Z. and Tamtaji, O.R., 2019. How probiotic bacteria influence the motor and mental behaviors as well as immunological and oxidative biomarkers in multiple sclerosis? A double blind clinical trial. Journal of Functional Foods 52: 8-13.
-
Saville, S.H., Younes, J.A., Paraskevakos, G. and Venema, K., 2025. The prebiotic landscape: history, health and physiological benefits and regulatory challenges – an IPA perspective part 1. Beneficial Microbes. https://doi.org/10.1163/18762891-BJA00056
-
Schulz, K.F., Altman, D.G. and Moher, D., 2010. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMC Medicine 8: 18. https://doi.org/10.1186/1741-7015-8-18
-
Shanahan, F., Ghosh, T.S. and O’Toole, P.W., 2023. Human microbiome variance is underestimated. Current Opinion in Microbiology 73: 102288. https://doi.org/10.1016/J.MIB.2023.102288
-
Sies, H., Berndt, C. and Jones, D.P., 2017. Oxidative stress. Annual Review of Biochemistry 86: 715-748.
-
Soto-Brambila, A.P., Ortiz, G.G., Rivero-Moragrega, P., Briones-Torres, A.L., Gonzalez-Ortiz, L.J. and Pacheco-Moises, F.P., 2018. Relapsing remitting multiple sclerosis and its relationship with the immune system and oxidative stress. Current Immunology Reviews 14: 15-23.
-
St-Amant, A. and Bergdahl, A., 2023. A systematic review and meta-analysis of randomized controlled trials investigating the effects of probiotics on oxidative stress in healthy adults. Clinical Nutrition ESPEN 54: 180-186. https://doi.org/10.1016/J.CLNESP.2023.01.016
-
Tramacere, I., Del Giovane, C., Salanti, G., D’Amico, R. and Filippini, G., 2015. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis. Cochrane Database of Systematic Reviews 9.
-
Wang, P., Xie, K., Wang, C. and Bi, J., 2014. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis. European Neurology 72: 249-254.
-
Zheng, H.J., Guo, J., Jia, Q., Huang, Y.S., Huang, W.J., Zhang, W., Zhang, F., Liu, W.J. and Wang, Y., 2019. The effect of probiotic and synbiotic supplementation on biomarkers of inflammation and oxidative stress in diabetic patients: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 142: 303-313. https://doi.org/10.1016/J.PHRS.2019.02.016
-
Zheng, H.J., Guo, J., Wang, Q., Wang, L., Wang, Y., Zhang, F., Huang, W.J., Zhang, W., Liu, W.J. and Wang, Y., 2021. Probiotics, prebiotics and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition 61: 577-598. https://doi.org/10.1080/10408398.2020.1740645
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 120 | 120 | 63 |
| Full Text Views | 6 | 6 | 2 |
| PDF Views & Downloads | 15 | 15 | 5 |
The effects of probiotics supplementation on serum markers of oxidative stress in relapsing-remitting multiple sclerosis: a randomised, double-blind, placebo-controlled clinical trial
In: Beneficial MicrobesSearch for other papers by N. Mohy in
Current site
Google Scholar
PubMed
Search for other papers by S. Sanaie in
Current site
Google Scholar
PubMed
Search for other papers by S. Rahnemayan in
Current site
Google Scholar
PubMed
Search for other papers by M. Yousefi in
Current site
Google Scholar
PubMed
Search for other papers by M. Talebi in
Current site
Google Scholar
PubMed
Research Center for Evidence-Based Medicine, Iranian EBM Center: A Joanna Briggs Institute Center of Excellence, Tabriz University of Medical Sciences, Tabriz, Iran
Tabriz USERN Office, Universal Scientific Education and Research Network (USERN), Tabriz, Iran
Search for other papers by A. Naseri in
Current site
Google Scholar
PubMed
Abstract
Oxidative stress is a significant contributor to neuronal damage in multiple sclerosis (MS), marked by an imbalance in reactive oxygen species and antioxidant defences. Probiotics may modulate oxidative stress and improve antioxidant levels. This double-blind, randomised, placebo-controlled clinical trial aimed to evaluate the effects of probiotics supplementation on serum oxidative stress markers and endogenous antioxidants in patients with relapsing-remitting MS (RRMS). Ninety RRMS patients with expanded disability status scale [EDSS] < 4 were randomised into two groups: a probiotics group (Lactocare®) and a placebo group, and received the interventions twice daily for four months. Serum levels of oxidative stress markers (malondialdehyde [MDA]), endogenous antioxidants (glutathione peroxidase [GPx] activity, superoxide dismutase [SOD], catalase activity [CAT], glutathione [GSH]), and total antioxidant capacity (TAC) were measured at baseline and post-treatment. Fifty-five patients, including 26 patients in the probiotic group and 29 patients in the placebo group, completed the study. Both groups showed significant within-group improvements in GPx activity, SOD, and GSH levels, as well as reductions in MDA levels (
Iranian Registry of Clinical Trials: IRCT20220713055465N2, registration date: 2023.5.9
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 120 | 120 | 63 |
| Full Text Views | 6 | 6 | 2 |
| PDF Views & Downloads | 15 | 15 | 5 |
